Pharmacologic Strategies for the Treatment of Acute Respiratory Distress Syndrome: The Horizon is Getting Closer

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;1:319-323.

2. Bernard GR, Artigas A, Brigham KL. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.

3. Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest. 1999;116:74S-82S.

4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.

5. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.

6. Pittet JF, MacKersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med. 1997;155:1187-1205.

7. Matthay MA. Conference summary: acute lung injury. Chest. 1999;116(suppl):119S-126S.

8. Azoulay E, Darmon M, Delclaux C, et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med. 2002;30:781-786.

9. Adult respiratory distress syndrome and neutropenia [letter]. N Engl J Med. 1987;316:413-414.

10. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med. 1982;3:35-56.

11. Kinoshita M, Ono S, Mochizuki H. Neutrophil-related inflammatory mediators in septic acute respiratory distress syndrome. J Intensive Care Med. 2002;17:308-316.

12. Groeneveld AB, Raijmakers PG, Hack CE, Thijs LG. Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome. Cytokine. 1995;7:746-752.

13. Endo S, Inada K, Ceska M, et al. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflamm. 1995;45:136-142.

14. Lee WL, Downey GP. Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med. 2001;164:896-904.

15. Redl H, Schlag G, Bahrami S, Schade U, Ceska H, Stutz O. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a promate bacteremia model. J Infect Dis. 1991;164:388.

16. Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest. 1990;86:1945-1953.

17. Zeiher BG, Matsuoka S, Kawabata K, Repine JE. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med. 2002;30:S281-S287.

18. Baird BR, Cheronis JC, Sandhaus RA. O2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J Appl Physiol. 1986;68:1394-1403.

19. Weiser MR, Pechet TT, Williams JP, et al. Experimental murine acid aspiration injury is mediated by neutrophils and the alternative complement pathway. J Appl Physiol. 1997;83:1090-1095.

20. Knight PR, Druskovich G, Tait AR, Johnson KJ. The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology. 1992;77:772-778.

21. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest. 1995;96:107-116.

22. Carney DE, McCann UG, Schiller HJ, et al. Metalloproteinase inhibition prevents acute respiratory distress syndrome. J Surg Res. 2001;99:245-252.

23. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation. 1999;100:400-406.

24. Mitsuhashi H, Nonaka T, Hamamura I, Kishimoto T, Muratani E, Fujii K. Pharmacological activities of TEI-8362, a novel inhibitor of human neutrophil elastase. Br J Pharmacol. 1999;126:1147-1152.

25. Ahn CM, Sandler H, Saldeen T. A leukocyte elastase inhibitor reduces thrombin-induced pulmonary oedema in the rat: mechanisms of action. Pulmonary Pharmacol Ther. 1998;11:291-299.

26. Sakamaki F, Ishizaka A, Urano T, et al. Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 1996;153:391-397.

27. Miyazaki Y, Inoue T, Kyi M, Sawada M, Miyake S, Yoshizawa Y. Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNF alpha) and activated neutrophils in isolated perfused rabbit lungs. Am J Respir Crit Care Med. 1998;157:89-94.

28. Kawabata K, Hagio T, Matsumoto S, et al. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med. 2000;161:2013-2018.

29. Tamakuma S, Shiba T, Hirasawa H. A phase III clinical study of neutrophil elastase inhibitor ONO-5046 Na in SIRS patients. J Clin Ther Med (Japan). 1998;14:289-318.